Laurus Labs schedules investor meets on May 27, June 4

0 min read     Updated on 22 May 2026, 05:19 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Laurus Labs announced it will participate in analyst and institutional investor meetings in Mumbai on May 27 and June 4, 2026. The company stated no unpublished price sensitive information will be shared during these interactions.

powered bylight_fuzz_icon
40952934

*this image is generated using AI for illustrative purposes only.

Laurus Labs has intimated the stock exchanges regarding its schedule of analyst and institutional investor meetings. The company will participate in these conferences pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The meetings are scheduled to take place in Mumbai. The company clarified that no unpublished price sensitive information would be shared during these interactions.

Schedule of Meetings

The following table outlines the dates, events, and types of interactions planned for the upcoming investor conferences:

Date Analyst / Investors / Event Place Type of Interaction
May 27, 2026 360 ONE Capital (B&K) 16th Annual Investor Conference - TRINITY INDIA 2026 Mumbai In-Person Meeting
June 04, 2026 Citi 2026 India Conference Mumbai In-Person Meeting

The company noted that the dates of these meetings are subject to change due to exigencies on the part of investors or the company. The intimation was signed by G. Venkateswar Reddy, Company Secretary & Compliance Officer.

Historical Stock Returns for Laurus Labs

1 Day5 Days1 Month6 Months1 Year5 Years
+1.30%+3.51%+23.39%+40.55%+130.89%+166.41%

What strategic updates or pipeline developments might Laurus Labs highlight to institutional investors at these conferences to boost market confidence?

How could increased institutional investor engagement at these conferences influence Laurus Labs' stock performance and foreign institutional ownership in the near term?

Will Laurus Labs use these investor meetings to address concerns about its recent financial performance or provide guidance on its CDMO and ARV business recovery trajectory?

Laurus Labs Issues Newspaper Notice on TDS Requirements for 2nd Interim Dividend for FY 2025-26

2 min read     Updated on 09 May 2026, 11:31 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Laurus Labs Limited filed a disclosure on May 08, 2026, enclosing newspaper advertisements published in Business Standard and Prajasakti on May 07, 2026, notifying shareholders of TDS requirements for the 2nd Interim Dividend of ₹1.20/- (60%) per equity share for FY 2025-26. Under the Income Tax Act 2025, TDS at 10% applies to resident shareholders on dividends exceeding ₹10,000, while non-residents are subject to 20% plus surcharge and cess or applicable DTAA rates. Shareholders were required to submit relevant documents, including Form 121 or Form 41, to secretarial@lauruslabs.com on or before May 14, 2026.

powered bylight_fuzz_icon
39766820

*this image is generated using AI for illustrative purposes only.

Laurus Labs Limited filed a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, on May 08, 2026, enclosing copies of newspaper advertisements published on May 07, 2026. The advertisements appeared in Business Standard (English) and Prajasakti (Telugu), notifying shareholders about the submission of TDS-related documents pertaining to the 2nd Interim Dividend for FY 2025-26.

Dividend Details and Record Date

The Board of Directors, at their meeting held on April 30, 2026, approved the payment of a 2nd Interim Dividend of ₹1.20/- (60%) per equity share of ₹2/- each for the Financial Year 2025-26. The Record Date for this dividend was set as May 08, 2026.

TDS Framework Under the New Income Tax Act, 2025

Pursuant to the notice, shareholders were informed that under the Income Tax Act 2025, which officially replaced the Income Tax Act, 1961 effective April 01, 2026, dividends distributed or paid to shareholders remain fully taxable in their hands at their applicable income tax slab rates. For the Tax Year 2026-27, companies are mandated to deduct tax at source (TDS) on dividends paid to resident individuals at a standard rate of 10%, applicable only if the aggregate dividend amount exceeds ₹10,000 in a tax year — a threshold increased from the previous ₹5,000 limit. These provisions have been restructured and consolidated under Section 393 of the new Income Tax Act, 2025.

Eligible resident shareholders may submit a single consolidated Form 121 (which replaced the previous Forms 15G and 15H) to the Company to avoid TDS deduction.

TDS Rates for Resident Shareholders

The prescribed TDS rates for resident shareholders are as follows:

Particulars: TDS Rate
With PAN: 10% or as may be notified by the Government of India
Without / Invalid PAN: 20% or as may be notified by the Government of India
Submission of declaration in Form 121: NIL

Shareholders are requested to update their PAN with their depository participants to avail the benefit of the lower TDS rate and to enable the Company to issue TDS Certificates. Shareholders eligible to receive dividends above ₹10,000/- but without taxable income may submit Form 121 by sending an email to secretarial@lauruslabs.com on or before May 14, 2026.

TDS Requirements for Non-Resident Shareholders

For non-resident shareholders, TDS is applicable at 20% plus applicable Surcharge and Cess, or the applicable Tax Treaty Rate under the Double Tax Avoidance Treaty (DTAA) between India and their country of residence, whichever is lower. To avail treaty benefits, non-resident shareholders were required to submit the following documents to secretarial@lauruslabs.com on or before May 14, 2026:

  • Declaration for "No Permanent Establishment" in India
  • Beneficial Ownership Declaration
  • Tax Residency Certificate (TRC) for Tax Year 2026-27
  • Form 41 (which officially replaced Form 10F under the new Income Tax Rules, 2026 and the Income Tax Act, 2025, effective April 01, 2026)
  • Copy of Indian PAN (if available)

Additional Shareholder Instructions

Shareholders whose email IDs and/or bank account details for receipt of dividend are not registered with their Depository Participants were requested to register or update such details with their respective Depository Participants. The notice was also made available on the Company's website at www.lauruslabs.com .

The disclosure was signed by G. Venkateswar Reddy, Company Secretary & Compliance Officer, Laurus Labs Limited, dated May 08, 2026.

Historical Stock Returns for Laurus Labs

1 Day5 Days1 Month6 Months1 Year5 Years
+1.30%+3.51%+23.39%+40.55%+130.89%+166.41%

How might the transition from the Income Tax Act, 1961 to the new Income Tax Act, 2025 impact overall dividend distribution strategies for Indian pharmaceutical companies like Laurus Labs in FY 2026-27?

Could the increased TDS exemption threshold of ₹10,000 (up from ₹5,000) lead to a higher proportion of retail shareholders opting out of TDS deductions, and how might this affect company compliance workloads?

How is Laurus Labs' dividend payout trend for FY 2025-26 compared to previous fiscal years, and does the 2nd interim dividend signal stronger future earnings or cash flow generation?

More News on Laurus Labs

1 Year Returns:+130.89%